Skip to main content
. 2022 Jan 9;6(1):ytac004. doi: 10.1093/ehjcr/ytac004
Case 1
Day
0 First dose of coronavirus disease 2019 (COVID-19) Vaccine Moderna. Patient remained without symptoms
36 Second dose of COVID-19 Vaccine Moderna
37 General malaise and fatigue, later chest discomfort
41 Hospital admission
41–44 Intermediate care unit
No heart rhythm anomalies
Steady resolution of symptoms
44 No symptoms
Transfer to general ward
Cardiac magnetic resonance imaging (MRI) confirms myocarditis
45 and 46 Resolution of wall motion abnormalities and normalization of troponin-T
[Admission of Case 2]
47 Discharge of Patient 1
Case 2
Day
0 First dose of COVID-19 Vaccine Moderna. Patient remained without symptoms
47 Second dose of COVID-19 Vaccine Moderna
48 Arthralgia and general malaise, fever
49 Epigastric pain
50 Transfer from tertiary centre and hospital admission
51 Coronary angiography, coronary artery disease ruled out
50–54 Intermediate care unit
Heart failure therapy
No heart rhythm anomalies
Slow resolution of symptoms
53 Cardiac MRI confirms myocarditis
54 No epigastric pain
Decrease of troponin-T
Transfer to general ward
56 No symptoms
Resolution of wall motion abnormalities
Discharge of Patient 2